(Q84107291)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Satoru Iwasa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Takako Eguchi Nakajima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Kenichi Nakamura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Atsuo Takashima

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Ken Kato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Tetsuya Hamaguchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Yasuhide Yamada

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Yasuhiro Shimada

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

15 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

21-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21573919%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10120-011-0056-y

1 February 2020

exact match

0 references

cites work

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

12 December 2020

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

12 December 2020

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

1 reference

12 December 2020

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

12 December 2020

An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer.

1 reference

12 December 2020

Phase II study of weekly paclitaxel by one-hour infusion for advanced gastric cancer

1 reference

12 December 2020

Patterns of initial recurrence in completely resected gastric adenocarcinoma

1 reference

12 December 2020

Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer

1 reference

12 December 2020

Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 960

1 reference

12 December 2020

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.

1 reference

12 December 2020

Recurrence following curative resection for gastric carcinoma

1 reference

12 December 2020

Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie

1 reference

12 December 2020

Adenocarcinoma of the stomach: Review of 1,497 cases

1 reference

12 December 2020

Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients

1 reference

12 December 2020

Phase I study of protracted venous infusion of 5-fluorouracil

1 reference

12 December 2020

A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites

1 reference

12 December 2020

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

1 reference

12 December 2020

Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

1 reference

12 December 2020